Clinical Trial

Venous Thromboembolism Prevention in Outpatients With Glioma

Name: Venous Thromboembolism Prevention in Outpatients With Glioma — clinical trial record (NCT05683808)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: VTE-POG

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open label study of apixaban for venous thromboembolism prevention in patients with newly diagnosed grade 4 glioma.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-01-04.

Status change: Not Yet Recruiting → Recruiting 2026-01-27

Trial Details

NCT Number	NCT05683808
Lead Sponsor	University of Vermont Medical Center Collaborators: Dartmouth-Hitchcock Medical Center, MaineHealth
Conditions	Glioblastoma, Astrocytoma, Venous Thromboembolism
Enrollment	40 participants
Start Date	2023-01-16
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-30